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Abbreviations 
 
CI  confidence interval 
CMAM  Community Management of Acute Malnutrition 
F-75  therapeutic milk used in stabilization phase of the treatment of SAM 
HIV  human immunodeficiency syndrome 
IQR  interquartile range 
MAM  moderate acute malnutrition 
MUAC  mid-upper arm circumference 
RCT   randomized controlled trial 
RUTF   ready-to-use-therapeutic-food 
SAM   severe acute malnutrition 
SD  standard deviation 
W/A  weight-for-age 
W/H  weight-for-height 
WHO  World Health Organization 
WHZ  weight-for-height z-score 
 
Measurements 
 
d  day  
cm  centimetre 
g  gram 
kcal  kilocalorie 
kg  kilogram 
mg  megajoule 
mm  milimetre 
n  number 
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Abstract 
 
Background 
Children presenting mild or moderate nutritional oedema are usually treated in outpatient 
care. However, it is still unclear whether such children presenting require special care and if 
they can be treated indifferently in inpatient or outpatient care. 
 
Methods 
We systematically searched Medline, Embase, the Cochrane Library and DARE for evidence 
on mortality, recovery, treatment duration, weight gain, cost-effectiveness and adverse events 
in children with nutritional oedema treated in outpatient care as compared to treatment in 
inpatient care or to treatment of marasmus in outpatient care. We complied with the PRISMA 
statement for reporting of systematic review.  
 
Results 
Eight studies met the inclusion criteria, among which six observational studies and two 
controlled trials. These two trials assessed outcomes of outpatient care after one week of 
inpatient stabilization, i.e. not direct outpatient care. The first trial in Malawi reported better 
results in outpatients than in inpatients (recovery: 72% vs 49%) probably related to more 
infections in inpatient care. The second trial in Bangladesh reported the reverse (recovery: 
67% vs 86%) but no food supplement was provide to outpatients. The recovery rates for 
outpatients ranged across studies from 69% to 96%. These rates were consistently higher than 
for those children with marasmus (range 33–81%) or marasmic kwashiorkor (range 45–71%), 
and mortality rates were consistently lower. No evidence on cost-effectiveness or adverse 
events was available. Overall, the quality of the evidence was low. 
 
Conclusion 
Oedematous malnutrition could plausibly be treated effectively in outpatient service. 
However, the quality of evidence was low and further good quality studies in various settings 
are required before conclusive guidance can be generated. 
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Background and objective 
 
Along with a low mid-upper arm circumference (MUAC <115 mm) or a low weight-for-
height <-3 z-score (WHZ; WHO 2006 growth standards), bilateral pitting oedema, also called 
nutritional oedema, is an independent indicator of severe acute malnutrition (SAM) in 6–59 
month old infants (1). Three grades of severity are distinguished: oedema + is defined as a 
mild oedema on both feet/ankles; oedema ++ is a moderate oedema on feet and lower legs, 
hands or lower arms; and oedema +++ is severe oedema generalized to feet, legs, hands, arms 
and face (2,3).  
 
The standard recommendation for the management of SAM has been inpatient care during the 
stabilization and rehabilitation phases (4). However, inpatient treatment is resource intensive 
and requires many skilled and motivated staff, which is often lacking in low- and middle-
income countries where SAM is common (3). Moreover, studies have shown that children 
with SAM could be adequately treated at home (5–8). These results have led to a revised 
classification that categorizes acute malnutrition in complicated cases, which require inpatient 
care in the first stage of treatment, and uncomplicated cases that can be treated in the 
outpatient setting or at the community level (3,9). In the absence of severe illness and if an 
adequate appetite is maintained, SAM is considered uncomplicated. Regarding nutritional 
oedema, only children with oedema +++ or oedema +/++ combined with either a low MUAC, 
poor appetite or a severe illness should be hospitalized in the first stage of the treatment (3). 
These recommendations apply in many countries. Among 33 national guidelines on 
Community Management of Acute Malnutrition (CMAM) collected by the Emergency 
Nutrition Network in November 2011 (http://cmamconference2011.org/latest-conference-
updates/), almost all admitted uncomplicated oedema +/++ to outpatient care if there was 
good appetite (Annex 1). There were only six countries in which nutritional oedema, 
regardless of its severity, was systematically referred for inpatient treatment (Angola, Mali, 
Mozambique, Niger, Tanzania and Zanzibar) and another two where only oedema + was 
admitted to outpatient care (Côte Ivoire and Kenya).  
 
A recent joint statement by the World Health Organization (WHO), the United Nations 
Children’s Fund and the World Food Programme also advocates treating children with SAM 
at the community level whenever possible (10). However, this guidance does not differentiate 
grades of oedema and states generically that “children can be transferred from facility to 
community-based care when their oedema is reduced” (10). Actually, it is still unclear 
whether children presenting nutritional oedema +/++ require special care and if they can be 
treated indifferently in inpatient or outpatient care, i.e. if the critical outcomes of survival and 
recovery are similar in both settings. Until now, the evidence has not been reviewed in a 
systematic way.  
 
We, therefore, aimed at summarizing the evidence on the effectiveness and safety of 
managing children >6 months with uncomplicated oedematous SAM grade +/++ in outpatient 
care. This assessment is done by comparison with results obtained in the in-patient treatment 
of similar cases or in the out-patient treatment of uncomplicated SAM children without 
oedema (low WHZ and/or low MUAC) (Table 1). The results of this review will inform 
future policies on a safe and effective management of oedematous malnutrition.  
 
Table 1  
Research question (SPICE criteria) 
  
Setting Low- and middle-income countries, primary health 
care 
Perspective/Population Children >6 months with oedematous SAM +/++, and 
good appetite or no medical complications 
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Intervention Community-based therapeutic care – outpatient 
management 
Comparison - Uncomplicated nutritional oedema +/++ treated in 
inpatient care or health service-based care  
- SAM cases without oedema treated in outpatient 
care 
Evaluation (1) short-term mortality 
(2) recovery rate 
(3) time to recover 
(4) weight, length, and MUAC gain 
(5) use of resources, costs 
(6) adverse effects 
 
2. Methodology 
2.1 Sources and key words for literature review 
We searched Medline via PubMed (http://www.ncbi.nlm.nih.gov), Embase 
(http://www.embase.com), the Cochrane Library (www.cochranelibrary.com) and DARE 
(http://www.crd.york.ac.uk). We also searched the Emergency Network website 
(http://ennonline.net/) for additional field reports, and screened the bibliography of included 
studies. 
 
We applied the following search strategy: 
 
#1. (((Nutrition Disorders[MeSH] OR Growth disorders[MeSH] OR malnutrition[MeSH] OR 
wast*) AND (oedema OR edema)) OR "Kwashiorkor"[Mesh] ) 
#2. (child[Mesh] OR infant[Mesh]) 
#3. ((Child Nutrition Disorders[MeSH] OR Infant Nutrition Disorders[MeSH]) AND edema) 
#4. (#1 AND #2) OR #3 
#5. (treatment OR rehabilitation OR management OR hospitalization OR community health 
services)  
#6. #4 AND #5 
#7. (editorial [pt] OR letter [pt] OR comment [pt]) 
#8. #6 NOT #7 
 
The search strategy was adapted to fit each individual database (Annex 2). We searched for 
studies published up to 08 July 2013. We contacted the authors whenever additional data or 
clarifications on the published studies were needed. All publications were integrated into 
Reference manager version 12 (ISI ResearchSoft, Thomson Reuters). 
2.2 Criteria of inclusion and exclusion 
We included all original studies combining the three following criteria: (i) observational or 
interventional studies reporting on the outpatient treatment of children >6 months with 
nutritional oedema. Studies including children with and without oedema were retained if the 
subpopulation with oedema represented ≥80% of the study population or if the results on 
children with oedema were reported separately; (ii) studies reporting on any of the following 
treatment outcomes: mortality; nutritional recovery; weight/length/MUAC gain; adverse 
effects; and cost or cost-effectiveness of treatment; and (iii) studies carried out in low- and 
middle-income countries, as defined by the World Bank. We excluded editorials, letters or 
comments; studies including only children older than 60 months of age; and studies in 
languages other than English, French and Spanish.  
 
 6 
2.3 Review process 
We first screened titles and abstracts of identified references based on the inclusion criteria. 
Papers for which the title and/or abstract indicated that inclusion criteria could be fulfilled 
were considered and read in full. Two researchers applied the selection process 
independently. In case of discrepancies, a third reviewer was consulted and the decision to 
include or exclude the paper was reached by consensus. Studies excluded at this second stage 
are reported, as well as the reason for their exclusion. Data from included studies were 
extracted in predefined standard tables by one reviewer (NH) and cross-checked by a second 
one (DR). 
 
2.4 Quality appraisal 
The quality appraisal for the selected studies was derived from the checklists of the Scottish 
Intercollegiate Guidelines Network (http://www.sign.ac.uk/methodology/checklists.html). We 
adjusted the existing checklist for cohort studies to fit case series, as this was the main design 
of included studies. The selected quality criteria were: (i) adequate sampling of subjects (i.e. 
study not performed on a very specific subpopulation with limited external validity); (ii) 
management of missing values (% incomplete data, % of loss-to-follow-up, potential effect of 
missing data on results assessed or discussed); (iii) quality of measurement (training of 
assessors described, double measurements of anthropometry parameters, quality control 
procedures, assessment of accuracy); and (iv) appropriate statistical analysis. Each item was 
rated independently by two reviewers as: adequately addressed; moderately addressed; poorly 
addressed; or not reported. Disagreement between reviewers was resolved by discussion until 
a consensus was reached. In cases of a disagreement, a third reviewer was consulted. We 
followed the PRISMA statement for good reporting of systematic reviews 
(http://www.prisma-statement.org/). 
2.5 Appraisal of program performance 
We compared the results reported in the studies with the international standards for good care 
of malnourished children (11). According to the Sphere guidelines, the main outcome 
indicators for success of management of severely malnourished children are mortality rates 
<10%, recovery rates >75%, a recovery time of 30–40 days, default rates <15% and weight 
gain > 8 g/kg/day. For fatality rate, we applied the method of Prudhon et al. to calculate the 
predicted case fatality rate and compare it to the actual case fatality rate as reported in the 
studies (12).  
3. Results 
 
We retrieved 999 references from the electronic databases of which 10 papers, reporting on 8 
original studies, were included (Figure 1). Ashworth et al. 1997 (13) reported in more detail 
on the cost-effectiveness of the controlled trial published in 1994 by Khanum et al. (14). 
Ciliberto et al. 2006 (6) reported on children with oedematous malnutrition treated in 
outpatient care whose outcomes had already been presented with a 75% overlap in a previous 
publication (15) (personal communication of Mark Manary). Annex 3 gives an overview of 
excluded studies and reasons for exclusion.  
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Figure 1: Flow chart of review 
 
 
 
* References found in the reference list of selected papers. None was retained for this review. 
 
3.1 Characteristics of studies 
None of the eight included studies was a randomized controlled trial (RCT) comparing the 
outcomes of children with uncomplicated oedema treated exclusively in outpatient vs 
inpatient setting (Table 2). Three controlled trials provided useful information, although their 
focus differed somewhat from our research question. An RCT with sequential allocation 
compared the outcomes of SAM children (98% with oedema) treated in inpatient, day care or 
home care after one week of day care in Bangladesh (13,14). Another non-RCT compared the 
outcomes of children with SAM (81% oedema) who received inpatient vs home-based care 
for the second phase of treatment for childhood malnutrition (6). Finally, an RCT compared 
the outcomes of two types of ready-to-use-therapeutic-food (RUTF) during home-based care 
of children with SAM (78% with nutritional oedema) (16). Five observational studies 
Records identified through database 
searching (n=1135): 
Medline (n=777), Embase (n= 324), 
Cochrane (n=32), DARE (n=2)  
Duplicates (n=136) 
Records after duplicates 
removed (n=999) 
Records excluded based 
on title and abstract 
(n=974) 
Full-text articles assessed for 
eligibility (n=36) 
Articles included in the review 
(n=10), reporting on 8 studies 
References manually 
selected (n=11)* 
Full text not fulfilling 
the inclusion criteria 
(n=26) 
- No data on oedema 
cases (n= 13) 
- No eodema cases in 
outpatient care (n=5) 
- Selected outcomes not 
reported (n = 5) 
- Different selection 
criteria for outpatients 
(n=1) 
- Other content (n=2) 
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reported on the outcomes of oedematous malnutrition (5,17–20), among which four treated 
children exclusively in an outpatient setting. Therefore, evidence on treatment of oedematous 
malnutrition treated in exclusive outpatient settings originated from five observational studies 
– although the study by Oakley et al. (16) was an RCT, it was observational in essence 
regarding the research question addressed in this review. Three additional studies provided 
evidence on the outcomes of oedematous malnutrition after one week of inpatient 
stabilization, two of which were RCTs aimed at comparing outcomes obtained with outpatient 
vs inpatient treatment (14,15).  
 
The gradation +/++/+++ was not used in any of the included studies. In three studies, oedema 
was graded as severe according to the depth of imprint that remains when the thumb is 
removed from the foot dorsum: >0.5 cm (6,15) or >1.0 cm (5,17). Children with severe 
oedema were excluded from these studies. No oedema gradation was defined in the remaining 
five studies. It is thus assumed that cases of severe oedema were included although the 
proportion was not reported (3,14,16,18,20). 
  
Five studies included a proportion of children who combined wasting and bilateral oedema, 
but reported results separately for marasmus, kwashiorkor or marasmic kwashiorkor treated 
as outpatients (6,16,18–20) (Table 5). Marasmic kwashiorkor was defined as the presence of 
bilateral pitting oedema and a WHZ <-3, except in one study in which wasted children were 
defined as having a WHZ <-2 (6). 
 
The population of children ranged from 6–60 months, but two studies excluded children 
under 10–12 months (6,14,15) and another included children until 120 months (3). The eight 
studies recruited a total of 9616 severely malnourished children, from which the majority 
(81%) had oedema; 75% of oedema cases were treated solely in outpatient. Nearly all studies 
(7/8) took place in African countries and six of eight studies occurred in Malawi. 
 
3.2 Outcomes of intervention 
Tables 3–5 summarize the outcomes of the therapeutic nutritional interventions.  
3.2.1 Recovery rate 
The recovery rates for children with oedema treated in outpatient care ranged across studies 
from 69% to 96% (Table 3). These rates were consistently higher than for those children with 
marasmus (range 33–81%) or marasmic kwashiorkor (range 45–71%). 
 
Two studies compared outcomes in children treated in outpatient care after one week of 
stabilization in inpatient setting vs full inpatient care (Table 4). In Malawi, the recovery rate 
of severely malnourished children (81% of whom presented oedema) managed in outpatient 
care during the second phase of treatment vs inpatient was, respectively, 72% and 49% at 
eight weeks (15). The proportion of children with oedema was equal in each group, but their 
specific recovery rates were not reported. However, the authors reported that in a subgroup of 
171 children with oedema who were treated exclusively in outpatient management the 
recovery rate was 89% (6). Another study in Bangladesh compared the recovery rate of SAM 
children (98% of whom presented with oedema) in inpatient care vs day care vs home care 
after one week of day care and found, respectively, 87%, 67% and 75% (14). At the start of 
home care, 80% of children still had oedema and all recovered (personal communication of 
the author). No food supplements were distributed in this latter group. 
 
3.2.2 Mortality rate 
The mortality rates for children with nutritional oedema treated in outpatient care reported in 
six studies ranged from 1% to 4%, but peaked at 16% in a seventh study (18) (Table 3). One 
study in Malawi found a mortality rate of 16% in children with kwashiorkor (18). In that 
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study, 70% of mortality occurred during inpatient care, of which 53% occurred during the 
first four days of admission, suggesting that children had medical complications (also linked 
with high HIV prevalence). Nevertheless, mortality was also lower in the group with 
kwashiorkor (16%) compared to marasmic (47%) and marasmic kwashiorkor (42%). The 
comparative mortality rates in children with marasmus, kwashiorkor or marasmic 
kwashiorkor treated in outpatient care were reported in four studies (6,18-20) (Table 5). The 
mortality rates for children with kwashiorkor ranged from 0% to 4% and were consistently 
lower than those with marasmus (range from 4% to 5%) or marasmic kwashiorkor (range 
from 7% to 14%). 
 
The comparison of the mortality rate in severely malnourished children treated in inpatient vs 
outpatient care after inpatient stabilization was reported in two studies from Malawi and 
Bangladesh (14,15) (Table 4). In Malawi, the mortality rate was 5.4% in inpatient and 3.0% 
for home-based therapy with RUTF. In Bangladesh, the mortality rate was 3.5% in inpatient, 
5% in day care and 3.5% at home (after one week of day care). The higher mortality rate for 
inpatients in the Malawian study could have been associated with a higher incidence of 
infections for children who were hospitalized (fever, cough and diarrhoea; Wilcoxon’s signed 
rank test, p<0.001 for all comparisons). The proportion of children with oedema in the two 
studies varied from 81% (Malawi) to 98% (Bangladesh), but their specific mortality rates 
were not reported. However, the mortality rate of a subgroup of children with oedema treated 
solely in outpatient care in the Malawian study was 4.0% and none of the children with 
oedema died after the transfer to domiciliary care in Bangladesh (personal communication of 
the author).  
 
3.2.3 Weight/length/MUAC gain and recovery time 
Five studies reported the mean or median weight gain in children with oedema treated in 
outpatient setting. This did not vary much and ranged between 2.7 g/kg/day and 4.0 g/kg/day 
(5,6,14,17,19) (Table 3). All those studies, except the studies in Bangladesh and Ethiopia, 
calculated weight gain during the first four weeks of treatment and did not specify whether 
this weight gain was registered after loss of oedema. 
 
The median time to recover in outpatient care was only reported in two studies and ranged 
from 35 to 42 days (IQR 28–45) (14,19). In one study, the median time to recover was 
comparable for kwashiorkor and marasmic cases and longer for marasmic kwashiorkor cases 
(19) (Table 5). However, the weight gain after loss of oedema was slower in the kwashiorkor 
group.  
 
One study in Bangladesh compared the median time to recover in children treated in home 
care after one week of day care vs day care vs inpatient care (14). The group treated at home 
took significantly longer to lose oedema (respectively, 19, 13 and 11 days) and to recover 
(respectively, 35, 23 and 18 days) and the weight gain after loss of oedema was slower than in 
the other two groups (Table 4). It is important to highlight that there was no nutritional 
support for the group of children treated at home in this study. On the contrary, in the 
Malawian study (80% oedema) (15) the weight gain during the eight weeks of treatment was 
higher in the outpatient group treated with RUTF (3.7 g/kg/day) compared to the inpatient 
group (3.0 g/kg/day) (Table 4). This study calculated weight gain during the first four weeks 
of treatment (total duration of eight weeks) and did not mention whether weight gain was 
taken after loss of oedema in the subgroup of children with oedematous malnutrition.  
 
Only three studies reported on mean length/height and MUAC gain in children with oedema 
treated in outpatient care (5,6,17) (Table 3). These were consistent and ranged for 
length/height gain between 0.24 and 0.39 mm/day and for MUAC gain between 0.2 and 0.3 
mm/day. The rate of MUAC and length gain was higher in the outpatient group (with 
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distribution of RUTF) compared to the inpatients in one study with 80% oedema (15) (Table 
4). 
 
3.2.4 Costs 
Only one study explored the cost per child for SAM treated in inpatient care vs day care vs 
home care after one week of day care and found that the latter was four times more cost 
effective than inpatient care (13) (Table 4). However, the parental costs were highest for 
domiciliary care as no food supplements were provided. No studies explored the cost per 
child for the specific group of children with oedema.  
3.2.5 Adverse events 
Default rates 
The default rates for children with oedema treated in outpatient care were reported in six 
studies and varied between 3.6% and 15% (Table 3). In the study from Malawi with 15% 
drop-out, children were first treated in a tertiary hospital (18). Another study in Bangladesh 
found the lowest defaulter rate in inpatient care (1%), followed by outpatient care (4%) and 
day care (17%) (14) (Table 4). In the group of children treated in outpatient care, all 
defaulters occurred during the first week of day care (personal communication of the authors). 
Defaulting appeared similar in the group of children with kwashiorkor (range from 1% to 
15%) compared to marasmic children (range from 6% to 19%) (four studies; Table 5).  
 
Infection rate 
One study explored the prevalence of fever, cough and diarrhoea as secondary outcomes (15). 
The group of children who were managed in inpatient setting had twice the incidence of 
symptoms of infection during their recovery periods than the children in home-based 
treatment with RUTF. This could have influenced the outcome of inpatient vs outpatient 
treatment in this study and contributed to the higher mortality rate and lower recovery rate in 
the group of inpatients. 
 
3.3 Quality appraisal 
Table 6 summarizes the quality appraisal for the selected studies. Overall, the quality of the 
evidence was low. The definition of oedema was poorly or not defined in five of the eight 
studies. The precision and accuracy of anthropometric measurement was not addressed in 
most of the studies, which may influence the reliability of outcome measurements (recovery, 
weight/height/MUAC gain). Weight gain was sometimes measured during the first four 
weeks of treatment and it was not mentioned whether assessment was done after resolution of 
oedema (5,6,17). 
 
4. Discussion 
This systematic review did not retrieve direct evidence on the effectiveness of managing 
children >6 months with uncomplicated oedematous malnutrition grade +/++ in the outpatient 
vs inpatient setting as no study with a design appropriate to address such a question was 
retrieved. However, eight studies reported indirect evidence either by a comparison of 
outcomes in oedema cases treated in outpatient care after one week of institutionalized 
rehabilitation vs inpatient care, or case series of oedema cases treated in outpatient.  
 
Among the uncomplicated cases of oedematous malnourished children treated exclusively in 
outpatient setting, recovery rates exceeded 87% and case fatality rates remained below 4%. 
The default rates remained below 10%, indicating that outpatient management is an 
acceptable option for the caretakers. These figures conform with the Sphere Guidelines and 
the Prudhon index for case fatality rate (11,12). One study exceeded the Sphere standards, but 
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data suggested that there were many complicated cases with high case fatality rates (also 
linked with high HIV prevalence) during the first four days of inpatient stabilization (18). It 
is, however, quite difficult to disentangle from the reported results what part of this higher 
mortality can be attributed to either more severe cases at entry than in other studies, cross-
infection during hospitalization or suboptimal inpatient care. Also in the study in Bangladesh 
the weight gain in children with oedema treated in outpatient care did not meet the minimum 
Sphere standards (14). The authors of that study suggested that this was due to the absence of 
food supplementation in the outpatient treatment group. It needs, however, to be highlighted 
that the procedure to assess weight gain was not uniform over the studies and that Sphere 
standards are not necessarily adapted to the specific group of children with oedema neither for 
outpatient treatment.  
 
Only two studies allowed the comparison of outcomes for outpatient care vs inpatient care 
(14,15). It is worth mentioning that the outpatient care occurred after one week of inpatient 
stabilization in both studies. In Ciliberto et al. results were much better in outpatient care than 
in inpatient care, and the higher infection incidence during rehabilitation in the former group 
was presented by the authors as an explanatory factor (15). In Khanum et al., the 
rehabilitation was longer and the recovery rate lower in outpatients than in inpatients, but as 
already explained above children in outpatient care did not receive food supplements (14). In 
five other studies (Table 6), the mortality rate was lower and the recovery rate higher in 
children with kwashiorkor than in children with marasmus or marasmic kwashiorkor. 
 
These are encouraging findings indicating that severely malnourished children with oedema 
and no other medical complications can be effectively treated in outpatient care. However, 
caution is required before generalizing these results to any case of oedematous malnutrition 
for three reasons. First, the severity of oedema was poorly defined in all studies. The only 
three studies assessing the severity of oedema did so by measuring the depth of the thumb 
imprint on the dorsum of the foot, not by referring to the grading +/++/+++. Whether the 
good results observed across the studies included in this review relate to populations with a 
majority of cases presenting a mild oedema (grade +) is unknown, but the fact that the worst 
results were observed in studies where children underwent a first week of inpatient care might 
be an indication in that direction (14,15,18). Conversely, worse outcomes in more severe 
oedema cases could have been masked by the reporting of mean values as none of the studies 
stratified their results by grade of oedema at entry. Second, differences in nutritional status 
between defaulters and remainders were not described in the majority of the studies. It is 
possible that defaulters were in worse condition than remainders, as suggested in two studies 
(5,16), and that their outcomes were also worse. Although the default rates were relatively 
low in most studies, these figures may add to death rates. Moreover, most studies were 
observational, and the presence of selection bias was difficult to assess, particularly in the 
retrospective case series (19,20). It is striking that death rates were higher in the three trials 
(14-16) than in the observational studies, with the exception of the study by Sadler et al. (18). 
Lastly, six of the eight studies had been carried out in Malawi where the prevalence of HIV is 
high and where the ratio kwashiorkor/marasmus in SAM children is potentially higher than in 
other settings. The external validity of the results is thus unknown, as the patho-physiology of 
oedematous malnutrition is still poorly understood and may vary in different regions. 
 
There were also variations in the management procedures between studies. International 
guidelines recommend administration of antibiotics as part of the case management of SAM 
cases in outpatient (10). However, the systematic prescription of antibiotics occurred only in 
four of eight included studies (14,15,18,19). Nevertheless, this did not seem to have an impact 
on the mortality and recovery rates. This coincides with the findings of a retrospective cohort 
study in which uncomplicated oedematous cases treated with amoxicillin did not have better 
outcomes for mortality and recovery than children who did not have routine antibiotics (20).  
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No cost-effectiveness evaluation was included in our studies for the specific group of children 
with oedema treated in outpatient. However, a study in Bangladesh found that home-based 
treatment was four times lower than centre-based care and was preferred by mothers (14). 
This result related at least partially to the fact that no food supplementation was provided to 
the outpatient group in that study. Another review highlighted the scarcity of experimental 
evidence on cost-effectiveness of CMAM and that more funding should be invested in 
rigorous evaluation of that parameter (21).  
 
In conclusion, our review showed that oedematous malnutrition can be treated effectively in 
outpatient service. However, the quality of evidence was low and further good quality studies 
in various settings are required before conclusive guidance can be generated. Outpatient 
treatment of nutritional oedema already occurs in many programmes. A thorough evaluation 
of these programs would complement this review. Outcomes stratified by degree of 
nutritional oedema (+/++/+++) are particularly needed. This review also found that marasmic 
kwashiorkor patients had a higher risk of death and complications. These patients require 
intensive care, monitoring and cautious F-75 based feeding regimens of phase one therapeutic 
care that are not possible in outpatient treatment (3). This also emphasizes the need to 
combine indicators of SAM, in contradiction with the current WHO guidance of using WHZ, 
MUAC or bilateral pitting oedema independently (1). Future RCT should also include 
assessment of cost-effectiveness and coverage of the intervention.  
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Table 2  
Characteristics of included studies reporting on outpatient treatment of oedematous malnutrition 
Reference Country 
Period 
(month) 
No. 
SAM 
Prevalence of 
oedema (%) 
Prevalence 
oedema and 
not wasteda 
(%) 
Definition 
of oedema 
Admission 
criteria 
Intervention 
Oedema 
direct 
outpatient 
(%) 
Recovery 
criteria 
Type of study 
Amthor 2009 
(17) 
Malawi 5 826 99 71 
Non-severe 
<1 cm pitting 
6–60 months, W/H 
<70% and/or 
oedema and 
appetite 
Outpatient, RUTFb 100 
W/H ≥85% 
(8 weeks) 
O 
Ciliberto 2005 
(15); Ciliberto 
2006 (6)c 
Malawi 7 645 81 NR 
Mild <0.5 cm 
pitting 
10–60 months, 
“mild” oedema 
and/or W/H <-3 SD 
and appetite (no 
complications if 
direct outpatient) 
Second phase in 
inpatient therapy 
(n=113) vs home-
based RUTFb after 1 
week hospitalization 
(n= 532) 
39 
W/H >-2 (8 
weeks) and 
oedema 
resolved (4 
weeks) 
Non-randomized 
(stepped wedge 
designd) controlled 
comparative trial 
Collins 2002 (19) Ethiopia 3.5 170 38 30 
Present or 
absent 
6–120 months, 
W/H ≤70% or 
oedema 
Outpatient, RUTF 4.2 
MJ/day and 24.3 g 
protein/d and Famix 
8.26 MJ/d  
100 
W/H ≥85% 
and no 
oedema 
O retrospective 
Khanum 1994 
(14); Ashworth 
1996 (13) 
Bangladesh 12 473 98e 15 
Present or 
absent 
12–60 months, 
oedema and/or W/H 
<60% 
 
Inpatient (n=100) vs 
day care (n=200) vs 
home care after 1 
week day care (n=173)  
No food 
supplementation in 
home care 
0 W/H >80% 
RCT with 
sequential 
allocationf 
Linneman 2007 
(5) 
Malawi 12 2131 98 NR 
Mild and 
moderate <1 
cm pitting 
6–60 months, 
SAM: oedema 
and/or W/H < 70% 
and appetite 
Outpatient, RUTFb  77g 
Oedema 
resolved 
and W/H 
>85% 
O 
Oakley 2010 (16) Malawi 10 1874 78 67 
Present or 
absent 
6–59 months, 
SAM: oedema 
and/or W/H <-3SD 
and appetite 
Outpatient, RUTF 
25% milk (n=945) vs 
15% milk (n=929) 
100 
W/H >-2 
SD and no 
oedema 8 
weeks 
RCT, double blind 
Sadler 2008 (18) Malawi 12 1044 78 68 
Present or 
absent 
6–60 months, W/H 
<70% and/or 
oedema 
Home-based RUTF 
170 kcal/kg/d + family 
ration 700 kcal/d after 
inpatient stabilization  
0 W/H >85% O 
Trehan 2010 (20) Malawi 24 2453 80 NR 
Present or 
absent 
6–59 months, 
SAM: oedema 
and/or W/H <-3 SD 
and appetite, 
uncomplicated 
Outpatient, RUTFb 
with 7 d amoxy 
(n=498) vs no amoxy 
(n=1955) 
100 
W/H >-2 
SD and no 
oedema (4 
weeks and 
12 weeks) 
O retrospective 
No. = number; NR = not reported; O = observational 
a Wasted defined by anthropometric measurement W/H <-3 SD, except in Ciliberto 2006 W/H <-2 SD.  
b RUTF 175 kcal/kg/d and 5.3 g protein/kg/d for 8 weeks.  
c 75% overlap in population with oedema treated exclusively in outpatient (personal note from author) (n=171 vs n=219). 
d First three weeks of centre participation; only inpatient.  
e 80% still had oedema at start of outpatient (personal note from author).  
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f Allocation to treatment group through daily rotation.  
g Proportion of SAM following 8 weeks; outpatient RUTF.  
 
Table 3  
Outcomes of severely malnourished child with oedema treated in outpatient care 
Reference 
No. 
oedema 
Mortality 
(%) 
No 
death 
Predicted No. 
death (12) 
Recovery 
(%) 
Median time to 
recover (d) 
(IQR) 
Mean weight gain 
(g/kg/d) +/- SD 
Mean length 
gain (mm/d) +/-
SD 
Mean MUAC 
gain (mm/d) +/- 
SD 
Use of resources 
cost/child 
Other adverse 
effects 
Amthor  
Malawi 2009 
(17)a 
819 0.9 8 8 93.7 NR 2.7±3.7 0.3±0.9 0.2±0.3 NR 
Default 3.6%, 
failure 1.8% 
Ciliberto 
Malawi 2005 
(6,15) 
171 4b 8 30  89b NR 2.8±3.2b 0.24±0.27b 0.3±0.4b NR 
Overall default 
9.6%, relapse 3% 
Collins 
Ethiopia 2002 
(19)c  
50 0 0 NR 96 42 (28–45) 
 
2.7 (0.0–.8)d 
 
NR NR NR 
Transferred 0%, 
default 4% 
Khanum 1994; 
Ashworth 1997 
Bangladesh 
(13,14)e 
170 3.5 6 NR 75 35 (NR) 4±NR NR NR 
Institutional cost 
$29/child, parental 
cost $9/child  
Default 4%, late 
exclusionf 17% 
Linneman  
Malawi 2007 
(5)g 
2090 1 29 64 89 NA 3.5±4.1 0.39±0.54 0.24±0.35 NR 
Default 7%, failure 
3% 
Oakley  
Malawi 2010 
(16)h 
1458 3.5 64 58  88 NR NR NR NR NR Default 3% 
Sadler Malawi 
2008 (18)  
731 16 117 NR 69 NR NR NR NR NR Default 15% 
Trehan Malawi 
2010 (20) 
1962 1.5 29 NR 87.7 NR NR NR NR NR 
Default 8.3 %, 
failure 2.5 
 
No. = number; NR = not reported; $ = United States dollar 
a Outcomes of SAM (99% oedema).  
b Outcomes for the group presenting oedema (kwashiorkor and marasmic kwashiorkor) and treated exclusive outpatient. Outcomes group oedema and no wasting in OTP (Ciliberto 2006): recovery 
95%, mortality 4%, default 1%, failure 1%.  
c Outcomes group oedema and no wasting in OTP.  
d Median weight gain (IQR).  
e Outcomes of SAM (98.5% oedema) in outpatient. 80% had oedema at start of home care; mortality 0%, recovery 100% in oedema and non-oedema cases. 
f Due to tuberculosis or blood transfusion. 
g Outcomes of SAM with oedema (98%) exclusively treated in outpatient (77%) were not reported separately.  
h Mortality (4%), defaulting (3%), failure (8%) and transfer (2%) only reported for the global group (kwashiorkor or marasmus or both).  
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Table 4  
Comparison of outcomes for different treatment approaches 
Reference Treatment 
Mortality 
(%) 
No. 
deaths 
Predicte
d no. 
deaths 
(12) 
Recovery 
(%) 
Time to 
recover 
(d) 
Weight 
gain 
(g/kg/d) ± 
SD 
Length 
gain 
(mm/d) ± 
SD 
MUAC 
gain 
(mm/d) ± 
SD 
Cost/child 
($a) 
institutional/
parental 
Prevalence 
fever ± SD 
(d) 
Prevalence 
cough ± SD 
(d) 
Prevalence 
diarrhoea ± 
SD (d) 
Relapse 
(%) 
Relapse 
(6month
s)b (%) 
Default 
rate 
Ciliberto 
2005 (15) 
Inpatient 6.2 10 9 49 NR 3.0±8.8 0.04±0.35 0.28±0.44 NA 1.8±3.3c 1.8±3.6c 1.3±2.7c 10.6 39.1 8.1b 
Outpatient (1 
inpatient) 
3.7 30 30 72 NR 3.7±4.3 0.20±0.33 0.42±0.71 NA 1.0±2.0c 0.8±2.4c 0.7±1.7c 6.2 2.2 9.8b 
Khanum 
1994; (14)
Ashworth 
1997 (13) 
Inpatient 3.5 7 NR 86.5 18 11 NR NR 155.9/3.1 NR NR NR NR NR 1.0 
Day care 5.0 10 NR 67.0 23 6 NR NR 59.3/4.5 NR NR NR NR NR 17.0 
Outpatient (1 
day care) 
3.5 6 NR 75.1 35 4 NR NR 29.4/9.4 NR NR NR NR NR 4.0 
 
No. = number; NR not reported  
a United States dollar. 
b Default rates in global study group of MAM and SAM.  
c Wilcoxon’s signed-rank test, p<0.001 for all comparisons. 
 
 16 
Table 5  
Comparison of outcomes of outpatient treatment in kwashiorkor – marasmic kwashiorkor – marasmus 
Reference Mortality (%) Recovery (%) Median time to recover (d) (IQR) Weight gain (g/kg/d) +-SD Defaulter (%) Transferred (%) 
 M K MK M K MK M K MK M K MK G M K MK M K MK 
Ciliberto 2006 (6) NR 4 7 NA 95 65 NR NR NR NR NR NR 4.0 NR 1 8 NR NR NR 
Collins 2002 (19) 5 0 14 81 96 71 42 (28–56) 42 (28–45) 56 (42–70) 4.8a (2.9–8.1) 2.7a (0.0–4.8) 4.0a (2.7–4.3) 5 6 4 0 9 0 14 
Oakley 2010b (16) NR NR NR 70 88 NR NR NR NR NR NR NR 3 NR NR NR NR NR NR 
Trehan 2010 (20) 3.7 1.5 NR 75.1 87.7 NR NR NR NR NR NR NR 9 11.8 8.3 NR NR NR NR 
Sadler 2008 (18) 47 16 42 33 69 38 NR NR NR NR NR NR 16.2 19 15 20 NR NR NR 
 
M = marasmus, K = kwashiorkor; MK = marasmic kwashiorkor defined as oedema and wasted W/H <-3 SD, except for Ciliberto 2006 where wasted is defined as W/H <-2 SD; G = global malnutrition (M or K or 
MK); NR = not reported 
a Median weight gain (IQR). 
b Mortality (4%), defaulting (3%), failure (8%), weight gain (2.2 mg/kg/d), MUAC gain (0.15 mm/d), and transfer (2%) only reported for the global group. 
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Table 6  
Quality appraisal studies reporting on outcome of children with oedema 
Reference 
Sources + 
methods 
of 
selection 
correctly 
described 
Reliability of measures 
Statistical 
analysis 
Missing data Other comments 
    
Training 
of 
assessors 
Definition 
of oedema 
Double 
measurement 
Quality 
control 
(method) 
Refere
nce 
testa 
  
Oedema 
assessed 
in all 
children  
% 
drop-
out 
Differences of 
drop-outs 
assessed 
  
Amthor 2009 M A A NR NR NR 
P (median test, 
p) 
NR 3.6 NR Case series, Malawi (high HIV prevalence) 
Ciliberto 2005; 2006 M NR A NR NR NR 
A, intention to 
treat analysis, 
difference in CI 
95% 
A 9.6 NR 
Non-randomized controlled trial, Malawi, 
high HIV prevalence 
Collins and Sadler 2002 M A NR NR A NR 
P, (χ2 for 
proportions) 
A 5 NR 
Retrospective, no inpatient facility available  
All oedema cases treated outpatient 
Khanum 1994; Ashworth 1997 M NR NR NR NR NR NR NR 9.8 NR 
RCT with sequential allocation  
Main focus cost-effectiveness analysis 
Linneman 2007  M A A NR NR NR NR A 7.4 
Drop-outs had 
lower 
anthropometri
c indices 
Case series, Malawi (high HIV prevalence) 
Oakley 2010  M A NR A A A 
A, Intention to 
treatment, Cox 
regression 
(M,K) 
NR 3 
Drop-outs 
were younger 
 and more 
marasmatic 
(RCT double blind, two types RUTF), 
Malawi 
Sadler 2008 P A NR NR A NR NR NR 15 A Case series, initial inpatient, high HIV % 
Trehan 2010  P NR NR NR NR NR 
A (for the 
assessment of the 
differences due to 
antibiotic) 
NR 8.3 NR 
retrospective, uncomplicated SAM and 
RUTF, all oedema cases treated outpatient 
            
 
NR = not reported; M = moderate; A = appropriate; P = poor  
a Results of index test were interpreted relative to the reference standard. 
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Annexes 
Annex 1: Overview of 33 guidelines on CMAM 
Country Year Oedema +/++ in outpatient? 
Afghanistan 2008 Yes 
Angola 2008 No 
Bangladesh 2010 Yes 
Botswana 2009 Yes 
Burundi 2010 Yes 
Central African Republic unknown Yes 
Democratic Republic of the Congo 2008 Yes 
Djibouti 2009 Yes 
Ethiopia 2007 Yes 
Eritrea Extract with admission/discharge criteria - 2010 Yes 
Ghana 2010 Yes 
Honduras Revisions without date Yes 
Côte Ivoire 2010 Only oedema + 
Kenya 2008 Only oedema + 
Madagascar 2009 Yes 
Malawi Draft without date Yes 
Mali 2007 No 
Mauretania 2007 Yes 
Mozambique 2010 No 
Republic of Niger 2009 No 
Rwanda No date Yes 
Sierra Leone 2009 Yes 
Somalia 2010 Yes 
Republic of the Sudan 2009 Yes 
Republic of South Sudan 2009 Yes 
Sri Lanka 2007 Yes 
Tanzania 2010 No 
Tajikistan 2009 Yes 
Togo 2009 Yes 
Uganda 2010 Yes 
Yemen 2008 Yes 
Zanzibar 2010 No 
Zimbabwe 2008 Yes 
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Annex 2 
Key words used for database other than Medline 
 
The key words used in:  
 Cochrane library: “nutritional edema”  
 Embase: “(((‘kwashiorkor’/exp OR (‘malnutrition’/exp AND ‘edema’/exp) OR (‘nutritional 
deficiency’/exp AND ‘edema’/exp) OR (wast* AND ‘edema’/exp)) AND (‘infant’/exp OR 
‘child’/exp)) AND (‘community care’/exp OR treatment OR ‘rehabilitation’/exp OR 
‘management’/exp OR ‘hospitalization’/exp)) NOT (‘editorial’/exp OR ‘letter’/exp OR comment)) ”, 
 DARE: “kwashiorkor OR (nutrition AND edema)” 
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Annex 3 
Studies excluded and reasons for exclusion 
 
1. Ashworth 2006 (22) 
Review examining the effectiveness of 16 studies with community-based rehabilitation for treatment of SAM. 
Rehabilitation is referring to the second phase of treatment. No reporting on prevalence of oedema. 
2. Birem-Etchebes 1988 (23) Intervention: All kwashiorkor and marasmic cases were hospitalized. Qualitative study. No data on main outcomes. 
3. Bredow 1994 (24) 
45 children with severe, moderate or mild malnutrition (following the Gomez classification) followed in outpatient. 
Only four (9%) oedema and no reporting of outcomes of these children with oedema. 
4. Brown et al. 2009 (25) 
Review on community-based management of SAM and moderate acute malnutrition (MAM). No reporting on 
prevalence of oedema. 
5. Chaiken 2006 (26) No reporting of prevalence and outcomes of patients with oedema in outpatient.  
6. Chapko 1994 (27) RCT: comparison of hospital vs day care. 24% oedema. No reporting of outcomes in patients with oedema. 
7. Collins 2006 (3) Review on community based-management of SAM with RUTF. No reporting on prevalence of oedema. 
8. Diop 2003 (28) Inclusion after oedema disappeared.  
9. Fernandez-Concha 1991 (29) 
No reporting on prevalence of severely malnourished children with oedema, only 12 cases of third degree 
malnutrition (W/A). 
10.  Gaboulaud 2007 (8) 
Comparison of inpatient, inpatient followed by home treatment and exclusive home treatment. Cases of oedema 
were excluded from group with exclusive home treatment. 
11.  Gossens 2012 (30) Children with oedema were treated in in-patient setting 
12.  Gueri 1985 (31) No reporting on prevalence oedema, no data on main outcomes. 
13.  Heikens 1989 (32) Exclusion of oedema cases in outpatient. 
14.  Husaini 1982 (33) Very small sample (five children with kwashiorkor). 
15.  Jansen 1986 (34) Supplementary feeding at home. No reporting on prevalence oedema, no data on main outcomes. 
16.  Kumari 1975 (35) No data on main outcomes. 
17.  Lapidus 2009 (36) 
Moderately and severely malnourished children were treated in inpatient (complications), outpatient or inpatient 
followed by outpatient. Risk factor analysis for mortality. No data on prevalence and outcomes of patients with 
oedema in outpatient. 
18.  Manary 2004 (37) 
Intervention: Testing of three dietary regimens, all obtained initial inpatient stabilization (>80% oedema during 
hospitalization). No reporting of prevalence and outcomes of patients with oedema during outpatient phase. 
19.  Manary 2008 (38) Review on management of MAM and SAM. No reporting on outcomes. 
20.  Ndekha 2004 (39) 
Idem as Manary 2004, but with HIV positive children. All obtained inpatient stabilization (<80% oedema). No 
reporting of prevalence and outcomes of patients with oedema in outpatient. 
21.  Prudhon 1997 (12) Model to calculate the number of deaths based on nutritional status (including presence of oedema). 
22.  Sandige 2004 (7) 
Intervention: All obtained inpatient stabilization. 12% received exclusive outpatient. Percentage oedema and 
outcomes during outpatient phase is not reported. 
23.  Sadler (40) 
Evaluation of community-based treatment model of SAM. Prevalence of oedema 61%. Comparison between SAM 
with complications (78%) treated first in inpatient and those without complications treated indirectly in outpatient. 
Different triage criteria: Children with oedema ++/+++ were admitted in inpatient, children with oedema + in 
outpatient. The outcomes for children with oedema +/++/+++ were reported separately, but inconsistent with 
 21 
Collins 2006. 
24.  Schoffield 1996 (41) Review on causes of mortality in treatment of SAM. 
25.  Shah 1971 (42) Case report of 16 cases of Kwashiorkor. No data on main outcomes. 
26.  Tellier 1996 (43) No data on outcomes for SAM with oedema treated in outpatient. 
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